Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine

Clinical trial NCT00297856 · COMPLETED

Trial details

NCT number: NCT00297856
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Diphtheria Tetanus Acellular Pertussis

Start date: 2006-03-01
Primary completion: 2006-12-01
Enrollment: 10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.